【结 构 式】 |
【分子编号】60886 【品名】2-(butylamino)-N-(4-methoxy-2-nitrophenyl)-2-oxoacetamide 【CA登记号】 |
【 分 子 式 】C13H17N3O5 【 分 子 量 】295.2952 【元素组成】C 52.88% H 5.8% N 14.23% O 27.09% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(II)Treatment of the N-aryl oxalamic acid ethyl ester (I) with butylamine in toluene provides the oxalic diamide (II). The nitro group of (II) is then reduced to the corresponding amine (III) by catalytic hydrogenation over Pd/C. Subsequent thermal cyclization of the N-acyl phenylenediamine (III) leads to benzimidazole (IV). Hydrolysis of both the methyl ether and amide functions of (IV) with concentrated HBr furnishes 6-hydroxy-1H-benzimidazole-2-carboxylic acid (V). Then, coupling of acid (V) with 4-benzylpiperidine (VI) in the presence of TBTU gives rise to the desired amide
【1】 Nagy, J.; Domany, G.; Farkas, S.; Borza, I.; Horvath, C.; Bartane Szalai, G.; Kolok, S. (Gedeon Richter Ltd.); Amine derivs. as NMDA receptor antagonists. WO 0234718 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 60885 | ethyl 2-(4-methoxy-2-nitroanilino)-2-oxoacetate | C11H12N2O6 | 详情 | 详情 | |
(II) | 60886 | 2-(butylamino)-N-(4-methoxy-2-nitrophenyl)-2-oxoacetamide | C13H17N3O5 | 详情 | 详情 | |
(III) | 60893 | N-(2-amino-4-methoxyphenyl)-2-(butylamino)-2-oxoacetamide | C13H19N3O3 | 详情 | 详情 | |
(IV) | 60894 | N-butyl-6-methoxy-1H-benzimidazole-2-carboxamide | C13H17N3O2 | 详情 | 详情 | |
(V) | 60985 | 6-[4-(3-hydroxybutyl)-1-piperazinyl]-N-(6-methoxy-8-quinolinyl)hexanamide | C24H36N4O3 | 详情 | 详情 | |
(VI) | 26225 | 4-benzylpiperidine | 31252-42-3 | C12H17N | 详情 | 详情 |
Extended Information